We are live on ! Find out more
EAM

EULAV Asset Management Portfolio holdings

AUM $3.12B
1-Year Est. Return 13.38%
This Fund
S&P 500
This Quarter Est. Return
+8.71%
1 Year Est. Return
+13.38%
3 Year Est. Return
+70.33%
5 Year Est. Return
+92.94%
10 Year Est. Return
+482.74%
AUM
$1.96B
AUM Growth
+$104M
Cap. Flow
-$30.9M
Cap. Flow %
-1.58%
Top 10 Hldgs %
15.65%
Holding
315
New
29
Increased
67
Reduced
63
Closed
23

Top Buys

Rank Stock Value
1
SBAC icon
SBA Communications
SBAC
+$7.43M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$5.99M
3
NOW icon
ServiceNow
NOW
+$5.44M
4
BAC icon
Bank of America
BAC
+$5.34M
5
KITE
Kite Pharma, Inc.
KITE
+$5.32M

Top Sells

Rank Stock Value
1
CLC
Clarcor
CLC
+$10M
2
MBLY
Mobileye N.V.
MBLY
+$7.21M
3
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
+$6.44M
4
PX
Praxair Inc
PX
+$6.21M
5
MD icon
Pediatrix Medical
MD
+$4.91M

Sector Composition

Rank Sector Weight
1 Industrials 20.11%
2 Technology 17.38%
3 Healthcare 17.03%
4 Consumer Discretionary 13.92%
5 Financials 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STZ icon
101
Constellation Brands
STZ
$22.2B
$6.81M 0.35%
42,000
-5,000
-11% -$779K
CERN
102
DELISTED
Cerner Corp
CERN
$6.78M 0.35%
115,200
-11,000
-9% -$595K
JKHY icon
103
Jack Henry & Associates
JKHY
$10.7B
$6.78M 0.35%
72,800
+4,100
+6% +$378K
KITE
104
DELISTED
Kite Pharma, Inc.
KITE
$6.75M 0.34%
+86,000
New +$5.32M
SNX icon
105
TD Synnex
SNX
$19.4B
$6.36M 0.32%
113,600
– –
AAPL icon
106
Apple
AAPL
$4.89T
$6.32M 0.32%
176,000
– –
SF
107
Stifel
SF
$12.3B
$6.28M 0.32%
281,475
– –
AKAM icon
108
Akamai
AKAM
$16.8B
$6.27M 0.32%
105,000
+3,000
+3% +$197K
NVO
109
Novo Nordisk
NVO
$216B
$6.15M 0.31%
359,000
– –
MTN icon
110
Vail Resorts
MTN
$5.19B
$6.14M 0.31%
32,000
– –
PLUS icon
111
ePlus
PLUS
$2.33B
$6.06M 0.31%
179,600
+4,000
+2% +$123K
TMO icon
112
Thermo Fisher Scientific
TMO
$211B
$6.04M 0.31%
39,300
+1,000
+3% +$153K
URBN icon
113
Urban Outfitters
URBN
$5.99B
$5.94M 0.3%
250,000
+80,000
+47% +$2.07M
XRAY icon
114
Dentsply Sirona
XRAY
$2.59B
$5.9M 0.3%
94,500
+5,600
+6% +$337K
ICPT
115
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$5.88M 0.3%
52,000
+6,000
+13% +$700K
PFE icon
116
Pfizer
PFE
$140B
$5.82M 0.3%
179,180
+83,266
+87% +$2.63M
HDB icon
117
HDFC Bank
HDB
$119B
$5.68M 0.29%
302,000
– –
AGN
118
DELISTED
Allergan plc
AGN
$5.61M 0.29%
23,480
-10,500
-31% -$2.45M
TOL icon
119
Toll Brothers
TOL
$14B
$5.6M 0.29%
155,000
-10,000
-6% -$333K
EL icon
120
Estee Lauder
EL
$29B
$5.51M 0.28%
65,000
-2,000
-3% -$165K
RSG icon
121
Republic Services
RSG
$66.7B
$5.5M 0.28%
87,500
– –
SYF icon
122
Synchrony
SYF
$23.7B
$5.49M 0.28%
160,000
+20,000
+14% +$717K
AVGO icon
123
Broadcom
AVGO
$1.82T
$5.47M 0.28%
250,000
– –
ESL
124
DELISTED
Esterline Technologies
ESL
$5.44M 0.28%
63,200
– –
ZD icon
125
Ziff Davis
ZD
$1.9B
$5.39M 0.27%
73,830
– –
3 4
5
6 7

Similar funds

DIG
DeepCurrents Investment Group New York $3.12B AUM 12.93% 1-Year Est. Return
AWM
Axxcess Wealth Management Carlsbad, California $3.12B AUM 21% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.12B AUM 25.62% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return

EULAV Asset Management's Q1 2017 Portfolio in Review

As of Q1 2017, EULAV Asset Management held 315 positions worth $1.96B, up 5.6% from $1.86B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

EULAV Asset Management's Q1 2017 filing shows 29 new, 67 increased, 63 reduced and 23 closed positions. Its largest new stake was SBA Communications: 67,300 shares worth $8.1M. The largest sale was Clarcor, an estimated $10M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 21% a quarter earlier, followed by Technology and Healthcare.

  • EULAV Asset Management's largest Q1 2017 buy was SBA Communications: 67,300 shares worth $8.1M.
  • EULAV Asset Management added most to Jazz Pharmaceuticals in Q1 2017, an estimated $5.99M increase.
  • EULAV Asset Management's biggest Q1 2017 reduction was Pediatrix Medical, cutting an estimated $4.91M.
  • EULAV Asset Management fully exited Clarcor in Q1 2017, selling an estimated $10M.
  • EULAV Asset Management's ten largest holdings make up 16% of its $1.96B portfolio in Q1 2017.
  • EULAV Asset Management opened 29 new positions and closed 23 in Q1 2017.
  • EULAV Asset Management's portfolio value rose 5.6% quarter-over-quarter to $1.96B.

Based on EULAV Asset Management's 13F filing for Q1 2017, filed 12 May 2017.